Specialized testing
Delivering value beyond the test result
Our commitment to improving patient outcomes propels the development of clinically impactful, patient-focused testing. Supported by clinical physicians and laboratory scientists with unmatched experience and expertise, our assays — several of which are unavailable elsewhere — deliver actionable answers that improve patient lives.
Our data-driven, evidence-based tests provide actionable answers for patients that clarify each patient’s unique healthcare journey.
Specialty testing menu
Collaborations that power innovation
We relentlessly innovate on behalf of patients to build tests of the future to help physicians impact more lives. Mayo Clinic Laboratories scientists and physicians are leaders in their fields and at the forefront of translating new ideas into meaningful solutions. Through groundbreaking collaborations with healthcare companies and diagnostics leaders, we simplify access to new and advanced laboratory tests.
Commitment to education
The exchange of knowledge is a founding principle at Mayo Clinic. In this tradition, we provide a wide range of education offerings and outreach consultation to help you drive continual improvement.
- Regionally based clinical specialists help guide best practices through physician education.
- Access to Mayo Clinic Laboratories' education offerings and Insight articles.
- Many courses offer CME credits.
- Online trainings are available, such as “Dangerous Goods Shipping,” and include printable certificates.
News and updates
The latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care.
Define mentorship, identify the roles and responsibilities of the mentor and the mentee, and outline the benefits of mentorship in the workplace.
PACE/FL - Four case studies to explore key diagnostic considerations when Lyme testing is negative, highlight the role of geographic exposure history, and demonstrate the utility of multiplex testing panels
In the first quarter of 2026, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
Learn how a phenotype-specific autoimmune neurology evaluation diagnosed a treatable autoimmune encephalitis condition that was missed with a traditional paraneoplastic evaluation.
Due to the Memorial Day holiday (recognized on Monday, May 25), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please note the following plans for Domestic and International shipping.
In this episode of the “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Wendy Daigle and Ellen Dijkman Dulkes for the first installment of a two-part series on skilled nursing facilities.
Discover how efficient, evidence-based serologic testing algorithms can accelerate Coccidioides infection diagnosis, simplify laboratory workflow, and provide practical benefits for laboratorians and healthcare professionals.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to reflect on the essential role of laboratory medicine during National Medical Laboratory Professionals Week. Dr. Pritt also welcomes Julia Lehman, M.D., a dermatologist and dermatopathologist at Mayo Clinic, to discuss innovative diagnostic tests for autoimmune diseases affecting the skin.
Find out how our testing uses neurofascin 155 IgG4 antibodies as a specific marker of chronic inflammatory demyelinating polyradiculoneuropathy.
New wtRNA-seq test detects fusions in 1,445 genes with high accuracy, improving cancer diagnosis, treatment decisions, and clinical trial eligibility.
Skilled nursing facilities and hospital laboratory outreach programs can be strong collaborators, delivering benefits across the care continuum.
Learn more about our CNS demyelinating disease testing through this case study focused on MOG-IgG as a marker of acute disseminated encephalomyelitis.